DIOVAN Safety Questions, DIOVAN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about DIOVAN. Our extensive database of DIOVAN adverse events and DIOVAN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about DIOVAN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




DIOVAN Safety Reports

Total DIOVAN reports: 1211.
DIOVAN FDA safety alerts: No.
Reported deaths: 101    Reported hospitalizations: 449.
Take DIOVAN Side Effects Survey or Share Your DIOVAN Story. DIOVAN Usage.

Showing 1-75 of 1211 Next >

Pharmacist from JAPAN reported DIOVAN problem on Feb 06, 2007. Male patient, 36 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. DIOVAN dosage: 40 MG/DAY. During the same period patient was treated with ADALAT. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Feb 06, 2007. Male patient, 76 years of age, was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, nasopharyngitis. DIOVAN dosage: 80 MG/DAY. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Feb 07, 2007. Male patient, 80 years of age, weighting 116.8 lb, was diagnosed with hypertension, cerebral infarction, parkinsonism and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: gait disturbance, parkinson's disease. DIOVAN dosage: 80 MG, QD. During the same period patient was treated with ASPIRIN, SERMION, MADOPAR. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Feb 08, 2007. Male patient, 50 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, dizziness postural, hyperchromic anaemia, vitamin b12 deficiency. DIOVAN dosage: 80 MG/DAILY. During the same period patient was treated with NORVASC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIOVAN problem on Feb 06, 2007. Female patient, 82 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, catheterisation cardiac abnormal, chest discomfort, coronary artery occlusion, dizziness. DIOVAN dosage: 160 MG, QD. During the same period patient was treated with ZESTRIL. Patient recovered.

DIOVAN problem was reported by a Consumer or non-health professional from BRAZIL on Feb 05, 2007. Female patient, 87 years of age, weighting 138.9 lb, was diagnosed with hypertension, osteoarthritis and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: femur fracture, myalgia, prosthesis implantation. DIOVAN dosage: 80 MG/DAY. During the same period patient was treated with GLUCOSAMINE. Patient recovered.

Consumer or non-health professional from reported DIOVAN problem on Oct 27, 2006. Male patient, 72 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, glomerular filtration rate decreased. DIOVAN dosage: unknown. During the same period patient was treated with AMLODIPINE. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Feb 07, 2007. Female patient, 75 years of age, weighting 108.0 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: aortic dissection, atrial fibrillation, bradycardia, chest pain, depression. DIOVAN dosage: 80 MG, QD. During the same period patient was treated with WARFARIN, ZYLORIC, LASIX, GASTER, ALDACTONE, ADALAT, PLETAL, PAXIL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported DIOVAN problem on Feb 07, 2007. Female patient, 42 years of age, weighting 180.8 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: adenoma benign, arrhythmia, blood pressure fluctuation, fatigue, feeling hot, formication, hypertension, hypoaesthesia. DIOVAN dosage: VALS 160 / AMLO 5 MG/DAY. During the same period patient was treated with ATENSINA, PURAN T. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Physician from TURKEY on Feb 07, 2007. Male patient, weighting 143.3 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, pancreatitis. DIOVAN dosage: 80 MG, QD. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported DIOVAN problem on Feb 12, 2007. Female patient was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: dermatitis. DIOVAN dosage: unknown. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Feb 08, 2007. Male patient, 70 years of age, was diagnosed with hypertension, cerebrovascular disorder and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: carotid artery stenosis, dizziness, hypoaesthesia, transient ischaemic attack, visual disturbance. DIOVAN dosage: 160 MG/DAY. During the same period patient was treated with ASPIRIN. Patient recovered.

Consumer or non-health professional from ARGENTINA reported DIOVAN problem on Feb 08, 2007. Female patient, 77 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, phlebitis, tremor. DIOVAN dosage: 80 MG, QD. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2007. Male patient, 72 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. DIOVAN dosage: 80 MG, QD. Patient recovered.

Consumer or non-health professional from GERMANY reported DIOVAN problem on Feb 08, 2007. Male patient was diagnosed with hypertension, gout and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, nightmare, tachyarrhythmia. DIOVAN dosage: unknown. During the same period patient was treated with VOLTAREN, ALLOPURINOL, METOPROLOL SUCCINATE. Patient recovered.

DIOVAN problem was reported by a Physician from GERMANY on Feb 12, 2007. Female patient was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: dermatitis exfoliative. DIOVAN dosage: unknown. Patient recovered.

Consumer or non-health professional from GERMANY reported DIOVAN problem on Feb 13, 2007. Female patient was diagnosed with tachycardia paroxysmal and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, bradycardia, tachycardia paroxysmal. DIOVAN dosage: 40 MG, BID. During the same period patient was treated with ISOPTIN, TAMBOCOR. Patient recovered.

DIOVAN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2007. Female patient, 37 years of age, was diagnosed with hypertension, menorrhagia and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea, menorrhagia, presyncope. DIOVAN dosage: 160MG VAL/12.5MG HCT, QD. During the same period patient was treated with DIOVAN HCT, ORAL CONTRACEPTIVE NOS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIOVAN problem on Feb 13, 2007. Female patient, 64 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: amnesia, flushing, hypertension, loss of consciousness, pain, transient ischaemic attack, urine odour abnormal. DIOVAN dosage: 80 MG TAB, QD. Patient recovered.

DIOVAN problem was reported by a Consumer or non-health professional from BRAZIL on Feb 16, 2007. Female patient, 63 years of age, weighting 187.4 lb, was diagnosed with hypertension, hypothyroidism, diabetes mellitus, blood cholesterol and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: obstruction, stent placement. DIOVAN dosage: VALS 160 / HCT 12.5 MG/DAY. During the same period patient was treated with SYNTHROID, PROPRANOLOL, AMARYL, SOMALGIN, LIPITOR, PLAVIX, ACTOS. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Feb 15, 2007. Female patient, 73 years of age, was diagnosed with hypertension, hypercholesterolaemia, arrhythmia and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: angina pectoris, chest pain, coronary artery stenosis, dyspnoea, stress cardiomyopathy. DIOVAN dosage: 80 MG DAILY. During the same period patient was treated with BEZATOL, BUFFERIN, ASPIRIN. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Consumer or non-health professional from DENMARK on Feb 16, 2007. Male patient, 39 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: coronary artery thrombosis, percutaneous coronary intervention. DIOVAN dosage: VALS 160 / HCT 25 MG/DAY. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Feb 16, 2007. Male patient, 67 years of age, was diagnosed with hypertension, atrial fibrillation and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: jaundice. DIOVAN dosage: 80 MG, QD. During the same period patient was treated with NORVASC, DIGOSIN, ASPIRIN, LASIX. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Feb 16, 2007. Female patient, 79 years of age, was diagnosed with hypertension, arrhythmia, diabetes mellitus, gastritis and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: cardiac failure, cardiac pacemaker replacement, cardiomegaly, chest discomfort, dyspnoea, sick sinus syndrome. DIOVAN dosage: 40 MG, QD. During the same period patient was treated with TAMBOCOR, THYRADIN, GASTER, MUCOSTA, LIPITOR. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Feb 14, 2007. Female patient, 73 years of age, weighting 143.3 lb, was diagnosed with hypertension, cerebral infarction, diabetes mellitus, pruritus, back pain and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: breast cancer, breast mass, lymphadenectomy, mastectomy. DIOVAN dosage: 80 MG/DAILY. During the same period patient was treated with ASPIRIN, ATELEC, NORVASC, NATEGLINIDE, AMARYL, HEPARINOID, FELDENE, EURAX. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2007. Male patient, 72 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. DIOVAN dosage: 80 MG, QD. Patient recovered.

Consumer or non-health professional from BRAZIL reported DIOVAN problem on Feb 07, 2007. Female patient, 42 years of age, weighting 180.8 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: adenoma benign, arrhythmia, blood pressure fluctuation, fatigue, feeling hot, formication, hypertension, hypoaesthesia. DIOVAN dosage: VALS 160 / AMLO 5 MG/DAY. During the same period patient was treated with ATENSINA, PURAN T. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Physician from TURKEY on Feb 07, 2007. Male patient, weighting 143.3 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, pancreatitis. DIOVAN dosage: 80 MG, QD. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Feb 20, 2007. Male patient, 76 years of age, was diagnosed with hypertension, atrial fibrillation, hyperlipidaemia and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, cell marker increased, cough, haematocrit decreased, haemoglobin decreased, interstitial lung disease, nasopharyngitis. DIOVAN dosage: unknown. During the same period patient was treated with BUFFERIN, CIBENOL, MEVALOTIN. Patient recovered.

DIOVAN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 19, 2007. Male patient, 42 years of age, weighting 302.9 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, hyperchlorhydria, nephrotic syndrome, oedema, pitting oedema, protein urine present, weight increased. DIOVAN dosage: 160 MG, QD. During the same period patient was treated with CRESTOR. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Feb 26, 2007. Female patient, 66 years of age, was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: aortic dissection, computerised tomogram abnormal, thrombosis. DIOVAN dosage: 160 MG/DAY. During the same period patient was treated with IFENPRODIL TARTRATE, LIPITOR, AMLODIPINE BESYLATE, GASTER D. Patient recovered.

DIOVAN problem was reported by a Pharmacist from JAPAN on Feb 20, 2007. Female patient was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, upper respiratory tract inflammation. DIOVAN dosage: 40 MG/DAY. During the same period patient was treated with FIBRATES. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Feb 26, 2007. Female patient, 76 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, haemodialysis, renal failure. DIOVAN dosage: 160 MG/DAY. During the same period patient was treated with INNOLET, INSULIN, LASIX, THYRADIN S, LENDORMIN, CALBLOCK, LIPITOR, ALFAROL. Patient died on 10/09/2006.

DIOVAN problem was reported by a Physician from JAPAN on Feb 21, 2007. Male patient, 74 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, blood lactate dehydrogenase increased, c-reactive protein increased, gamma-glutamyltransferase increased, hepatic function abnormal, prothrombin time shortened. DIOVAN dosage: 80 MG/DAY. During the same period patient was treated with CARDENALIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIOVAN problem on Feb 21, 2007. Female patient, 65 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic increased, cerebrovascular accident, feeling cold, headache, muscular weakness. DIOVAN dosage: 40 MG, QD. During the same period patient was treated with BENICAR, ASPIRIN, NORVASC, CADUET. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Pharmacist from JAPAN on Feb 21, 2007. Female patient was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: retinopathy. DIOVAN dosage: 80 MG/DAY. During the same period patient was treated with AMLODIPINE. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Feb 23, 2007. Male patient, 70 years of age, was diagnosed with hypertension, cerebral infarction and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: aphasia, carotid artery stenosis, dizziness, dyslalia, eyelid ptosis, haemoglobin decreased, hypoaesthesia, monoplegia, paralysis. DIOVAN dosage: 160 MG/DAY. During the same period patient was treated with ASPIRIN, PLETAL, ATELEC, LENDORMIN, LAC B, PHELLOBERIN A, INTEBAN. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Feb 23, 2007. Female patient, 78 years of age, weighting 88.18 lb, was diagnosed with hypertension, anaemia, gastritis, hyperuricaemia and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: anorexia, blood chloride decreased, blood sodium decreased, blood urea increased, haemoglobin decreased, hypoaldosteronism, hypochloraemia, hyponatraemia, malaise. DIOVAN dosage: 80 MG, BID. During the same period patient was treated with FERROMIA, CEREKINON, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIOVAN problem on Feb 22, 2007. Female patient, 72 years of age, was diagnosed with hypertension, hypertonic bladder, blood calcium decreased and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia. DIOVAN dosage: 160MG VAL/25MG HCTZ, UNK. During the same period patient was treated with VESICARE, CALCIUM. Patient recovered.

DIOVAN problem was reported by a Health Professional from UNITED STATES on Feb 23, 2007. Female patient, 45 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, lip swelling, swollen tongue, throat tightness. DIOVAN dosage: 160MG VAL/25MG HCT, QD. During the same period patient was treated with DIOVAN HCT, CARDIZEM. Patient recovered.

Consumer or non-health professional from BRAZIL reported DIOVAN problem on Feb 25, 2007. Male patient, 54 years of age, weighting 207.2 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, acute myeloid leukaemia, bone marrow transplant, diarrhoea, myelodysplastic syndrome. DIOVAN dosage: 40 MG, QD. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Feb 26, 2007. Female patient, 75 years of age, was diagnosed with hypertension, hypercholesterolaemia and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, c-reactive protein increased, gamma-glutamyltransferase increased, oedema, platelet count decreased, pleural effusion, protein urine present, rash, renal impairment. DIOVAN dosage: 80 MG/DAY. During the same period patient was treated with ALPRAZOLAM, LIVALO. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Feb 23, 2007. Female patient, 69 years of age, weighting 101.4 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood ketone body present, cerebral infarction, hypochloraemia, hyponatraemia, vomiting. DIOVAN dosage: 80 MG, BID. During the same period patient was treated with AMLODIN, GLYBURIDE, PLAVIX. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Feb 27, 2007. Female patient, 66 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: platelet count decreased, purpura. DIOVAN dosage: 40 MG, QD. During the same period patient was treated with AMLODIN. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Feb 27, 2007. Male patient, 76 years of age, weighting 125.7 lb, was diagnosed with hypertension, atrial fibrillation, hyperlipidaemia and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, cell marker increased, cough, haematocrit decreased, haemoglobin decreased, interstitial lung disease, nasopharyngitis. DIOVAN dosage: unknown. During the same period patient was treated with BUFFERIN, CIBENOL, MEVALOTIN, ARTIST. Patient recovered.

DIOVAN problem was reported by a Consumer or non-health professional from BRAZIL on Feb 27, 2007. Female patient, 84 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: arrhythmia, blood pressure increased. DIOVAN dosage: VLAS 160 / AMLO 5 MG/DAY. During the same period patient was treated with SOMALGIN, LASIX, DAFLON. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported DIOVAN problem on Feb 27, 2007. Female patient, 42 years of age, weighting 180.8 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: adenoma benign, arrhythmia, blood pressure fluctuation, cardiovascular disorder, fatigue, feeling hot, formication, hypertension. DIOVAN dosage: VALS 160 / AMLO 5 MG/DAY. During the same period patient was treated with ATENSINA, PURAN T. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Pharmacist from JAPAN on Feb 28, 2007. Male patient, 40 years of age, was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, diabetes mellitus insulin-dependent, dry mouth, pharyngolaryngeal pain. DIOVAN dosage: unknown. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Mar 09, 2007. Female patient, 66 years of age, was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: aortic dissection, cardiac failure, computerised tomogram abnormal, thrombosis. DIOVAN dosage: 160 MG/DAY. During the same period patient was treated with IFENPRODIL TARTRATE, LIPITOR, AMLODIPINE BESYLATE, GASTER D. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Mar 09, 2007. Female patient, 76 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, haemodialysis, renal failure. DIOVAN dosage: 160 MG/DAY. During the same period patient was treated with INNOLET, INSULIN, LASIX, THYRADIN S, LENDORMIN, CALBLOCK, LIPITOR, ALFAROL. Patient died on 10/09/2006.

Consumer or non-health professional from reported DIOVAN problem on Mar 02, 2007. Male patient, 72 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, glomerular filtration rate decreased. DIOVAN dosage: unknown. During the same period patient was treated with AMLODIPINE. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Mar 08, 2007. Male patient, 52 years of age, weighting 125.7 lb, was diagnosed with hypertension, insomnia, diabetic neuropathy, hyperlipidaemia, diabetes mellitus and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: cardiovascular disorder. DIOVAN dosage: 40 MG, QD. During the same period patient was treated with HALCION, ADALAT, CYANOCOBALAMIN, EPADEL, KINEDAK, LENDORMIN, INSULIN. Patient died on 11/10/2004.

Consumer or non-health professional from UNITED STATES reported DIOVAN problem on Mar 01, 2007. Male patient, 58 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, gastrooesophageal reflux disease, hallucination, auditory. DIOVAN dosage: 40 MG, QD. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Mar 01, 2007. Male patient, 80 years of age, weighting 136.7 lb, was diagnosed with parkinson's disease, cerebral infarction and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, cerebral infarction, convulsion, dementia, depressed level of consciousness, hemiparesis, hemiplegia, rhabdomyolysis, visual disturbance. DIOVAN dosage: 40 MG, BID. During the same period patient was treated with TICLOPIDINE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Mar 01, 2007. Male patient, 69 years of age, was diagnosed with hypertension, diabetes mellitus and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: aphasia, depressed level of consciousness, thrombotic stroke. DIOVAN dosage: 160 MG, QD. During the same period patient was treated with CALBLOCK, ACECOL, CARDENALIN, FLUITRAN, HUMACART, HUMALOG, TENORMIN, WYTENS. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Pharmacist from JAPAN on Mar 02, 2007. Female patient was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, upper respiratory tract inflammation. DIOVAN dosage: 40 MG/DAY. During the same period patient was treated with BEZATOL, LASIX, FIBRATES. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Mar 02, 2007. Female patient, 72 years of age, was diagnosed with hypertension, hypercholesterolaemia and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: cardiac pacemaker insertion, dizziness, sick sinus syndrome. DIOVAN dosage: 80 MG, QD. During the same period patient was treated with MEVALOTIN, PANTOSIN, MAGNESIUM OXIDE. Patient recovered.

DIOVAN problem was reported by a Consumer or non-health professional from on Mar 05, 2007. Female patient, 59 years of age, weighting 213.8 lb, was diagnosed with hypertension, cardiac disorder, hypercholesterolaemia, agitation, arthropathy and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, blood pressure increased, dysphonia, pharyngolaryngeal pain, tension. DIOVAN dosage: 160 MG, QD. During the same period patient was treated with HIGROTON, VASTAREL, ISOSORBIDE MONONITRATE, SOMALGIN, VYTORIN, LEXOTANIL, GLUCOSAMINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIOVAN problem on Nov 06, 2006. Female patient, 87 years of age, weighting 120.0 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dizziness, speech disorder, syncope, vertigo, visual disturbance. DIOVAN dosage: 160 MG, QD. During the same period patient was treated with HYDROCHLOROTHIAZIDE, METOPROLOL BY MYLAN, DILTIAZEM, VERAPAMIL, LISINOPRIL. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Consumer or non-health professional from VENEZUELA on Mar 05, 2007. Male patient, 51 years of age, was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: dry mouth, pruritus, thirst. DIOVAN dosage: 320 MG, QD. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Mar 06, 2007. Male patient, 74 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, blood lactate dehydrogenase increased, c-reactive protein increased, gamma-glutamyltransferase increased, hepatic function abnormal, prothrombin time shortened. DIOVAN dosage: 80 MG/DAY. During the same period patient was treated with CARDENALIN. Patient was hospitalized. Patient recovered.

DIOVAN problem was reported by a Pharmacist from JAPAN on Mar 06, 2007. Female patient, 59 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: complicated fracture, hypoaesthesia facial. DIOVAN dosage: 80 MG, BID. During the same period patient was treated with AMLODIN, FLUITRAN, SOLON, ULGUT, ALTAT. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIOVAN problem on Mar 06, 2007. Male patient, 41 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, chest pain, dizziness, hypertension, loss of consciousness, nightmare, pain in extremity. DIOVAN dosage: 80MG VAL / 12.5MG HCT, QD. During the same period patient was treated with EXCEDRIN, SINUTAB. Patient recovered.

DIOVAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 16, 2007. Male patient, weighting 150.0 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, pharmaceutical product counterfeit. DIOVAN dosage: unknown. Patient recovered.

Physician from NETHERLANDS reported DIOVAN problem on Mar 08, 2007. Female patient, 70 years of age, was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: depression. DIOVAN dosage: 160 MG, UNK. Patient recovered.

DIOVAN problem was reported by a Pharmacist from JAPAN on Mar 08, 2007. Male patient, 74 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, fall, loss of consciousness. DIOVAN dosage: 80 MG, ONCE/SINGLE. During the same period patient was treated with NORVASC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIOVAN problem on Mar 08, 2007. Female patient was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: burning sensation, diabetes mellitus. DIOVAN dosage: 320 MG, QD. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Mar 08, 2007. Female patient, 70 years of age, weighting 112.4 lb, was diagnosed with hypertension, atrial fibrillation, angina pectoris, gastritis, insomnia, diabetes mellitus and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, facial palsy, muscular weakness, thrombotic stroke. DIOVAN dosage: 40 MG, UNK. During the same period patient was treated with VASOLAN, CIBENOL, FRANDOL, GASTER D, LENDORMIN, DEPAS, HUMACART. Patient was hospitalized. Patient recovered.

Pharmacist from JAPAN reported DIOVAN problem on Mar 08, 2007. Male patient, 74 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: fall, loss of consciousness, vision blurred. DIOVAN dosage: 80 MG, ONCE/SINGLE. During the same period patient was treated with NORVASC. Patient recovered.

DIOVAN problem was reported by a Physician from CANADA on Mar 12, 2007. Female patient, 70 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, chest discomfort, chest pain, dizziness, dyspnoea, fatigue, headache, hypoaesthesia, pain in extremity. DIOVAN dosage: 160 MG, QD. During the same period patient was treated with IRBESARTAN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIOVAN problem on Mar 09, 2007. Female patient, 84 years of age, was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: alopecia, spinal column stenosis, spinal fusion surgery, spinal laminectomy. DIOVAN dosage: 320 MG, QD. Patient recovered.

DIOVAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 09, 2007. Male patient, 53 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, dry skin, knee operation. DIOVAN dosage: 80MG, UNK. During the same period patient was treated with ATENOLOL. Patient recovered.

Physician from JAPAN reported DIOVAN problem on Mar 09, 2007. Female patient, 28 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: oligohydramnios, premature labour, premature rupture of membranes. DIOVAN dosage: unknown. During the same period patient was treated with CARNACULIN, JUVELA. Patient recovered.

DIOVAN problem was reported by a Physician from JAPAN on Mar 08, 2007. Female patient, 66 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: purpura, thrombocytopenia. DIOVAN dosage: 40 MG, QD. During the same period patient was treated with AMLODIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported DIOVAN problem on Mar 20, 2007. Female patient, 84 years of age, was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: cardiac failure, pneumonia, renal impairment, torsade de pointes. DIOVAN dosage: unknown. Patient was hospitalized. Patient died.

Showing 1-75 of 1211 Next >

Ask Our Patient Community about DIOVAN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert
<